Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04982653 · ClinicalTrials.gov registry record · Phase 2
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
A Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT04982653: Recruiting Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04982653 is a Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 140 participants, above the 81-participant average among 13 other Metastatic Malignant Neoplasm in the Liver trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04982653, a Phase 2 study of Metastatic Malignant Neoplasm in the Liver and Primary Malignant Liver Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.
Primary Outcome
Definition of incisional hernia will be based on the European Hernia Society: Any abdominal wall gap with or without a bulge in the area of a postoperative scar perceptible or palpable by clinical examination or imaging. Assessment of the primary outcome will occur at 3, 6, and 12 months with a computed tomography scan/magnetic resonance imaging. Scans will be read and assessed for incisional hernia by 3 independent assessors blinded to the allocation. A correlation coefficient will be determine
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Surgical Procedure
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2022-01-04 |
| Est. Completion | 2026-04-30 |
| Phase | Phase 2 |
What NCT04982653 shows while recruiting
NCT04982653 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 81-participant average among 13 other Metastatic Malignant Neoplasm in the Liver trials with a reported enrollment target (73% higher).
The record links to 3 conditions, with Metastatic Malignant Neoplasm in the Liver appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04982653 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04982653 about?
NCT04982653 is a clinical study titled "Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy". This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an...
What is the current status of trial NCT04982653?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2022-01-04. Estimated completion is 2026-04-30.
What conditions does trial NCT04982653 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Liver, Primary Malignant Liver Neoplasm, Liver and Intrahepatic Bile Duct Neoplasm.
What interventions are being tested in trial NCT04982653?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Surgical Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT04982653?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04982653 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04982653's enrollment target sits among peer trials
140 3rd of 13 higher than 11 of 13 other Metastatic Malignant Neoplasm in the Liver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Malignant Neoplasm in the Liver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RECRUITING · Phase 2
-
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
ACTIVE NOT RECRUITING · Phase 2
-
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases
ACTIVE NOT RECRUITING · Phase 2
-
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
RECRUITING · Phase 1
-
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
RECRUITING · Phase 1
-
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI